Health Rounds: New type of blood thinner significantly reduces bleeding risk in trial
Patients with a common heart rhythm disorder who took an experimental blood-thinning drug had far fewer bleeding episodes ...
Hosted on MSN23m
Neoadjuvant Chemoradiation Plus Immunotherapy Boosts Responses in Esophageal Cancer
The phase III ESCORT-NEO trial evaluated camrelizumab in combination with chemotherapy versus chemotherapy alone in the ...